A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

NCT04655404 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

High Grade Glioma
Diffuse Intrinsic Pontine Glioma

Interventions

DRUG: Larotrectinib
PROCEDURE: Larotrectinib surgical

Sponsor

Nationwide Children's Hospital